| Year |
Citation |
Score |
| 2020 |
Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ. The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32102910 DOI: 10.1158/1055-9965.Epi-19-0963 |
0.332 |
|
| 2020 |
Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC. Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32102909 DOI: 10.1158/1055-9965.Epi-19-0905 |
0.319 |
|
| 2020 |
Kotalik A, Vock DM, Donny EC, Hatsukami DK, Koopmeiners JS. Dynamic borrowing in the presence of treatment effect heterogeneity. Biostatistics (Oxford, England). PMID 31977040 DOI: 10.1093/Biostatistics/Kxz066 |
0.302 |
|
| 2020 |
Kaizer AM, Koopmeiners JS. A fully Bayesian mixture model approach for identifying noncompliance in a regulatory tobacco clinical trial. Statistics in Medicine. PMID 31961448 DOI: 10.1002/Sim.8478 |
0.356 |
|
| 2019 |
Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK. The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S73-S80. PMID 31867651 DOI: 10.1093/Ntr/Ntz158 |
0.31 |
|
| 2019 |
Koopmeiners JS, Vock DM, Boatman JA, Carroll D, Colby SM, Donny EC, Hatsukami DK, Luo X, Tidey JW. The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S22-S25. PMID 31867648 DOI: 10.1093/Ntr/Ntz119 |
0.357 |
|
| 2019 |
Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK. Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S63-S72. PMID 31867637 DOI: 10.1093/Ntr/Ntz160 |
0.306 |
|
| 2019 |
Smith TT, Koopmeiners JS, Tessier KM, Davis EM, Conklin CA, Denlinger-Apte RL, Lane T, Murphy SE, Tidey JW, Hatsukami DK, Donny EC. Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine. American Journal of Preventive Medicine. 57: 515-524. PMID 31542129 DOI: 10.1016/J.Amepre.2019.05.010 |
0.314 |
|
| 2019 |
Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, et al. Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects. Addiction (Abingdon, England). PMID 31140663 DOI: 10.1111/Add.14695 |
0.332 |
|
| 2019 |
Leng E, Henriksen JC, Rizzardi AE, Jin J, Nam JW, Brassuer BM, Johnson AD, Reder NP, Koopmeiners JS, Schmechel SC, Metzger GJ. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens. Scientific Reports. 9: 6992. PMID 31061447 DOI: 10.1038/S41598-019-43486-Y |
0.349 |
|
| 2019 |
Nardone N, Benowitz NL, Smith TT, Denlinger-Apte R, Hatsukami DK, Koopmeiners JS, Ren Y, Donny EC. Reasons for Non-compliance in a Trial of Reduced Nicotine Cigarettes Tobacco Regulatory Science. 5: 87-93. DOI: 10.18001/Trs.5.1.8 |
0.32 |
|
| 2018 |
Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC. Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes. Tobacco Control. PMID 30385649 DOI: 10.1136/Tobaccocontrol-2018-054622 |
0.303 |
|
| 2018 |
Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, et al. Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. Jama. 320: 880-891. PMID 30193275 DOI: 10.1001/Jama.2018.11473 |
0.336 |
|
| 2018 |
Jin J, Zhang L, Leng E, Metzger GJ, Koopmeiners JS. Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Statistics in Medicine. PMID 29923345 DOI: 10.1002/Sim.7810 |
0.353 |
|
| 2018 |
Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Koopmeiners JS, Hatsukami D, Donny EC. Age Moderates Smokers' Subjective Response to Very Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 29718460 DOI: 10.1093/Ntr/Nty079 |
0.317 |
|
| 2018 |
Leng E, Spilseth B, Zhang L, Jin J, Koopmeiners JS, Metzger GJ. Development of a measure for evaluating lesion-wise performance of CAD algorithms in the context of mpMRI detection of prostate cancer. Medical Physics. PMID 29542824 DOI: 10.1002/Mp.12861 |
0.306 |
|
| 2017 |
Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC. Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks. Tobacco Control. PMID 28735272 DOI: 10.1136/Tobaccocontrol-2017-053689 |
0.31 |
|
| 2017 |
Boatman JA, Vock DM, Koopmeiners JS, Donny EC. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics (Oxford, England). PMID 28605411 DOI: 10.1093/Biostatistics/Kxx029 |
0.337 |
|
| 2017 |
Kaizer AM, Koopmeiners JS. Identifying optimal approaches to early termination in two‐stage biomarker validation studies Journal of the Royal Statistical Society Series C-Applied Statistics. 66: 187-199. DOI: 10.1111/Rssc.12163 |
0.33 |
|
| 2016 |
Denlinger RL, Smith TT, Murphy SE, Koopmeiners JS, Benowitz NL, Hatsukami DK, Pacek LR, Colino C, Cwalina SN, Donny EC. Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes. Tobacco Regulatory Science. 2: 186-203. PMID 29600258 DOI: 10.18001/Trs.2.2.9 |
0.31 |
|
| 2016 |
Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, et al. Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes. Tobacco Control. PMID 27856940 DOI: 10.1136/Tobaccocontrol-2016-053301 |
0.303 |
|
| 2016 |
Pacek LR, Vandrey R, Dermody SS, Denlinger-Apte RL, Lemieux A, Tidey JW, McClernon FJ, Bangdiwala AS, Drobes DJ, al'Absi M, Strasser AA, Koopmeiners JS, Hatsukami DK, Donny EC. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use. Drug and Alcohol Dependence. PMID 27590743 DOI: 10.1016/J.Drugalcdep.2016.08.620 |
0.31 |
|
| 2016 |
Cunanan KM, Koopmeiners JS. A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines. Statistics in Medicine. PMID 27545299 DOI: 10.1002/Sim.7087 |
0.301 |
|
| 2016 |
Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL. Estimations and Predictors of Non-Compliance in Switchers to Reduced Nicotine Content Cigarettes. Addiction (Abingdon, England). PMID 27367436 DOI: 10.1111/Add.13519 |
0.345 |
|
| 2016 |
Metzger GJ, Kalavagunta C, Spilseth B, Bolan PJ, Li X, Hutter D, Nam JW, Johnson AD, Henriksen JC, Moench L, Konety B, Warlick CA, Schmechel SC, Koopmeiners JS. Detection of Prostate Cancer: Multiparametric MR Imaging Models Developed by Using Registered Correlative Histopathologic Results. Radiology. 151089. PMID 26761720 DOI: 10.1148/Radiol.2015151089 |
0.326 |
|
| 2015 |
Koopmeiners JS, Feng Z. Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence. Statistics in Medicine. PMID 26537180 DOI: 10.1002/Sim.6790 |
0.496 |
|
| 2015 |
Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, et al. Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England Journal of Medicine. 373: 1340-1349. PMID 26422724 DOI: 10.1056/Nejmsa1502403 |
0.308 |
|
| 2015 |
Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 472-6. PMID 25515551 DOI: 10.1158/1055-9965.Epi-14-0739 |
0.314 |
|
| 2014 |
Rizzardi AE, Rosener NK, Koopmeiners JS, Isaksson Vogel R, Metzger GJ, Forster CL, Marston LO, Tiffany JR, McCarthy JB, Turley EA, Warlick CA, Henriksen JC, Schmechel SC. Evaluation of protein biomarkers of prostate cancer aggressiveness. Bmc Cancer. 14: 244. PMID 24708576 DOI: 10.1186/1471-2407-14-244 |
0.344 |
|
| 2013 |
Carlin BP, Zhong W, Koopmeiners JS. Discussion of 'small-sample behavior of novel phase I cancer trial designs' by Assaf P Oron and Peter D Hoff. Clinical Trials (London, England). 10: 81-5; discussion 88-. PMID 23345305 DOI: 10.1177/1740774512469313 |
0.306 |
|
| 2013 |
Zhong W, Carlin BP, Koopmeiners JS. Flexible link continual reassessment methods for trivariate binary outcome phase I/II Trials Journal of Statistical Theory and Practice. 7: 442-455. DOI: 10.1080/15598608.2013.772815 |
0.313 |
|
| 2012 |
Zhong W, Koopmeiners JS, Carlin BP. A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy. Statistics in Medicine. 31: 3885-95. PMID 22807126 DOI: 10.1002/Sim.5477 |
0.309 |
|
| 2012 |
Koopmeiners JS, Feng Z, Pepe MS. Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility. Statistics in Medicine. 31: 420-35. PMID 22238117 DOI: 10.1002/Sim.4430 |
0.47 |
|
| 2011 |
Koopmeiners JS, Feng Z. Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control Sampling. Annals of Statistics. 39: 3234-3261. PMID 24039313 DOI: 10.1214/11-Aos937 |
0.469 |
|
| 2010 |
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL. Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 70: 1448-60. PMID 20687218 DOI: 10.1002/Pros.21180 |
0.479 |
|
| 2010 |
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL. CYP17 polymorphisms and prostate cancer outcomes. The Prostate. 70: 1094-101. PMID 20503394 DOI: 10.1002/Pros.21143 |
0.509 |
|
| 2010 |
Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 258-64. PMID 20056646 DOI: 10.1158/1055-9965.Epi-09-0800 |
0.342 |
|
| 2009 |
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7. PMID 19836772 DOI: 10.1016/J.Juro.2009.08.026 |
0.513 |
|
| 2009 |
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Koopmeiners JS, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450 |
0.343 |
|
| 2009 |
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3231-7. PMID 19366831 DOI: 10.1158/1078-0432.Ccr-08-2190 |
0.34 |
|
| 2009 |
Pepe MS, Feng Z, Longton G, Koopmeiners J. Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility. Statistics in Medicine. 28: 762-79. PMID 19097251 DOI: 10.1002/Sim.3506 |
0.471 |
|
| 2009 |
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69: 363-72. PMID 19058137 DOI: 10.1002/Pros.20887 |
0.511 |
|
| 2009 |
FitzGerald LM, Karlins E, Karyadi DM, Kwon EM, Koopmeiners JS, Stanford JL, Ostrander EA. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis. Prostate Cancer and Prostatic Diseases. 12: 192-7. PMID 18762813 DOI: 10.1038/Pcan.2008.46 |
0.352 |
|
| 2009 |
Wright JL, Lin DW, Kwon EM, Kolb S, Feng Z, Koopmeiners J, Ostrander EA, Stanford JL. CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES Journal of Urology. 181: 777-777. DOI: 10.1016/S0022-5347(09)62164-9 |
0.502 |
|
| 2008 |
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, Cox A, Maier C, Vogel W, ... ... Koopmeiners JS, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2052-61. PMID 18708398 DOI: 10.1158/1055-9965.Epi-08-0317 |
0.343 |
|
| 2008 |
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1203-13. PMID 18483343 DOI: 10.1158/1055-9965.Epi-07-2811 |
0.487 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Rizzardi AE, Vogel RI, Koopmeiners JS, Forster CL, Marston LO, Rosener NK, Akentieva N, Price MA, Metzger GJ, Warlick CA, Henriksen JC, Turley EA, McCarthy JB, Schmechel SC. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. Cancer. 120: 1800-9. PMID 24668563 DOI: 10.1002/Cncr.28646 |
0.298 |
|
| 2018 |
Boatman JA, Vock DM, Koopmeiners JS. Efficiency and robustness of causal effect estimators when noncompliance is measured with error. Statistics in Medicine. PMID 30109713 DOI: 10.1002/Sim.7922 |
0.296 |
|
| 2019 |
Skubitz APN, Boylan KLM, Geschwind K, Cao Q, Starr TK, Geller MA, Celestino J, Bast RC, Lu KH, Koopmeiners JS. Abstract AP08: DEVELOPMENT OF A MULTI-PROTEIN CLASSIFIER FOR OVARIAN CANCER DETECTION BY SIMULTANEOUS MEASUREMENT OF 92 SERUM PROTEINS ON PROSEEK MULTIPLEX ONCOLOGY II PLATES Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Ap08 |
0.295 |
|
| 2017 |
Murphy SE, Sipe CJ, Choi K, Raddatz LM, Koopmeiners JS, Donny EC, Hatsukami DK. Low cotinine glucuronidation results in higher serum and saliva cotinine in African American compared to White smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28264876 DOI: 10.1158/1055-9965.Epi-16-0920 |
0.294 |
|
| 2016 |
Koopmeiners JS, Hobbs BP. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials. Statistical Methods in Medical Research. PMID 27587591 DOI: 10.1177/0962280216665418 |
0.294 |
|
| 2020 |
Sipe CJ, Koopmeiners JS, Donny EC, Hatsukami DK, Murphy SE. UGT2B10 genotype influences serum cotinine levels and is a primary determinant of higher cotinine in African American smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32532831 DOI: 10.1158/1055-9965.Epi-20-0203 |
0.294 |
|
| 2017 |
Kaizer AM, Koopmeiners JS, Hobbs BP. Bayesian hierarchical modeling based on multisource exchangeability. Biostatistics (Oxford, England). PMID 29036300 DOI: 10.1093/Biostatistics/Kxx031 |
0.293 |
|
| 2017 |
Cunanan KM, Koopmeiners JS. Hierarchical models for sharing information across populations in phase I dose-escalation studies. Statistical Methods in Medical Research. 962280217703812. PMID 28480828 DOI: 10.1177/0962280217703812 |
0.293 |
|
| 2017 |
Boylan KLM, Geschwind K, Koopmeiners JS, Geller MA, Starr TK, Skubitz APN. A multiplex platform for the identification of ovarian cancer biomarkers. Clinical Proteomics. 14: 34. PMID 29051715 DOI: 10.1186/S12014-017-9169-6 |
0.292 |
|
| 2014 |
Rudser KD, Bendert E, Koopmeiners JS. Sample size and screening size trade-off in the presence of subgroups with different expected treatment effects. Journal of Biopharmaceutical Statistics. 24: 344-58. PMID 24605973 DOI: 10.1080/10543406.2013.860154 |
0.29 |
|
| 2018 |
Gupta S, Agarwal N, Konety BR, Weight CJ, Thyagarajan B, Murugan PJ, Koopmeiners JS, Sonpavde G. Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.6_Suppl.Tps528 |
0.289 |
|
| 2020 |
Peterson RL, Koopmeiners JS, Smith TT, Murphy SE, Donny EC, Vock DM. Detecting participant noncompliance across multiple time points by modeling a longitudinal biomarker. Clinical Trials (London, England). 1740774520956949. PMID 32921152 DOI: 10.1177/1740774520956949 |
0.289 |
|
| 2015 |
Borgatti A, Winter A, Stuebner K, Koopmeiners J, Modiano JF, Vallera D. Abstract 1694: Preclinical evaluation of a novel bispecific targeted toxin for the treatment of sarcomas Cancer Research. 75: 1694-1694. DOI: 10.1158/1538-7445.Am2015-1694 |
0.289 |
|
| 2019 |
Skubitz AP, Boylan KL, Geschwind KA, Cao Q, Starr TK, Geller MA, Celestino J, Bast RC, Lu KH, Koopmeiners JS. Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multi-Protein Classifier for Ovarian Cancer Detection. Cancer Prevention Research (Philadelphia, Pa.). PMID 30709840 DOI: 10.1158/1940-6207.Capr-18-0221 |
0.288 |
|
| 2013 |
Zhong W, Koopmeiners JS, Carlin BP. A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials. Contemporary Clinical Trials. 36: 587-96. PMID 23583925 DOI: 10.1016/J.Cct.2013.03.011 |
0.288 |
|
| 2005 |
Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A, Horwith G, Pentel PR. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clinical Pharmacology and Therapeutics. 78: 456-67. PMID 16321612 DOI: 10.1016/J.Clpt.2005.08.007 |
0.287 |
|
| 2014 |
Cunanan K, Koopmeiners JS. Evaluating the performance of copula models in phase I-II clinical trials under model misspecification. Bmc Medical Research Methodology. 14: 51. PMID 24731155 DOI: 10.1186/1471-2288-14-51 |
0.286 |
|
| 2016 |
Dodd LE, Proschan MA, Neuhaus J, Koopmeiners JS, Neaton J, Beigel JD, Barrett K, Lane HC, Davey RT. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study. The Journal of Infectious Diseases. PMID 26908739 DOI: 10.1093/Infdis/Jiw061 |
0.285 |
|
| 2018 |
Kaizer AM, Hobbs BP, Koopmeiners JS. A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics. PMID 29359450 DOI: 10.1111/Biom.12841 |
0.285 |
|
| 2016 |
Tidey JW, Pacek LR, Koopmeiners JS, Vandrey R, Nardone N, Drobes DJ, Benowitz NL, Dermody SS, Lemieux A, Denlinger RL, Cassidy R, al'Absi M, Hatsukami DK, Donny EC. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 27613885 DOI: 10.1093/Ntr/Ntw199 |
0.285 |
|
| 2014 |
Koopmeiners JS, Modiano J. A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes. Clinical Trials (London, England). 11: 38-48. PMID 24082004 DOI: 10.1177/1740774513500589 |
0.284 |
|
| 2017 |
Jha GG, Gupta S, Tagawa ST, Koopmeiners JS, Vivek S, Dudek AZ, Cooley SA, Blazar BR, Miller JS. A phase II randomized, double-blind study of sipuleucel-T followed by IDO pathway inhibitor, indoximod, or placebo in the treatment of patients with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 35: 3066-3066. DOI: 10.1200/Jco.2017.35.15_Suppl.3066 |
0.284 |
|
| 2018 |
Cunanan KM, Koopmeiners JS. Efficacy/toxicity dose-finding using hierarchical modeling for multiple populations. Contemporary Clinical Trials. PMID 29936124 DOI: 10.1016/J.Cct.2018.06.012 |
0.284 |
|
| 2020 |
Borgatti A, Fieberg A, Winter AL, Stuebner K, Taras E, Todhunter D, Masyr A, Rendhal A, Vallera DA, Koopmeiners JS, Modiano JF. Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma. Veterinary and Comparative Oncology. PMID 32187827 DOI: 10.1111/Vco.12590 |
0.283 |
|
| 2006 |
Hecht SS, Carmella SG, Le KA, Murphy SE, Boettcher AJ, Le C, Koopmeiners J, An L, Hennrikus DJ. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 988-92. PMID 16702381 DOI: 10.1158/1055-9965.Epi-05-0596 |
0.282 |
|
| 2015 |
Konorev D, Koopmeiners JS, Tang Y, Franck Thompson E, Jensen J, Hatsukami D, Turesky RJ. Measurement of the Heterocyclic Amines 2-Amino-9H-pyrido[2,3-b]indole and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Urine: Effects of Cigarette Smoking. Chemical Research in Toxicology. PMID 26574651 DOI: 10.1021/Acs.Chemrestox.5B00401 |
0.281 |
|
| 2010 |
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300. PMID 19902366 DOI: 10.1007/S10552-009-9461-5 |
0.278 |
|
| 2013 |
Koopmeiners JS, Vogel RI. Early termination of a two-stage study to develop and validate a panel of biomarkers. Statistics in Medicine. 32: 1027-37. PMID 23413213 DOI: 10.1002/Sim.5622 |
0.274 |
|
| 2015 |
Pacek LR, Vandrey R, Tidey JW, Drobes DJ, Koopmeiners J, Umbricht A, Hatsukami D, Donny E. The impact of nicotine dose assignment on affect and depression during extended exposure to experimental Spectrum cigarettes: Findings from CENIC Project 1 Study 1 Drug and Alcohol Dependence. 156: e168-e169. DOI: 10.1016/J.Drugalcdep.2015.07.458 |
0.274 |
|
| 2017 |
Koopmeiners JS, Wey A. The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM. Journal of Biopharmaceutical Statistics. 1-15. PMID 28340333 DOI: 10.1080/10543406.2017.1293076 |
0.273 |
|
| 2017 |
Borgatti A, Koopmeiners JS, Sarver AL, Winter AL, Stuebner K, Todhunter D, Rizzardi AE, Henricksen JC, Schmechel S, Forster CL, Kim JH, Froelich J, Walz J, Henson MS, Breen M, et al. Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR. Molecular Cancer Therapeutics. PMID 28193671 DOI: 10.1158/1535-7163.Mct-16-0637 |
0.27 |
|
| 2006 |
Dudek AZ, Kmak KL, Koopmeiners J, Keshtgarpour M. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer. Lung Cancer. 51: 89-96. PMID 16290256 DOI: 10.1016/J.Lungcan.2005.09.002 |
0.266 |
|
| 2016 |
Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. The New England Journal of Medicine. 375: 1448-1456. PMID 27732819 DOI: 10.1056/Nejmoa1604330 |
0.252 |
|
| 2014 |
Powell S, Kaizer A, Koopmeiners JS, Iwamoto C, Klein M. High expression of class III β-tubulin in small cell lung carcinoma. Oncology Letters. 7: 405-410. PMID 24396456 DOI: 10.3892/Ol.2013.1734 |
0.25 |
|
| 2013 |
Misemer B, Skubitz A, Manivel C, Schmechel S, Cheng E, Henriksen J, Koopmeiners J, Skubitz KM. Relationship of FAP-alpha, ADAM12, WISP1, and SOX11 expression to tumor activity in aggressive fibromatosis: Demonstration of heterogeneity within and between cases. Journal of Clinical Oncology. 31: 10560-10560. DOI: 10.1200/Jco.2013.31.15_Suppl.10560 |
0.249 |
|
| 2010 |
Kothari R, Nagel C, Koopmeiners JS, Ivy JJ, Geller M, Salani R, Argenta PA. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer. Gynecologic Oncology. 119: 491-5. PMID 20888625 DOI: 10.1016/J.Ygyno.2010.08.026 |
0.249 |
|
| 2014 |
Bohrer LR, Chuntova P, Bade LK, Beadnell TC, Leon RP, Brady NJ, Ryu Y, Goldberg JE, Schmechel SC, Koopmeiners JS, McCarthy JB, Schwertfeger KL. Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation. Cancer Research. 74: 374-86. PMID 24197137 DOI: 10.1158/0008-5472.Can-13-2469 |
0.246 |
|
| 2005 |
Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. An Alternative Formula to the Cockcroft-Gault and the Modification of Diet in Renal Diseases Formulas in Predicting GFR in Individuals with Type 1 Diabetes Journal of the American Society of Nephrology. 16: 1051-1060. PMID 15716336 DOI: 10.1681/Asn.2004080692 |
0.246 |
|
| 2013 |
Carter JS, Koopmeiners JS, Kuehn-Hajder JE, Metzger GJ, Lakkadi N, Downs LS, Bolan PJ. Quantitative multiparametric MRI of ovarian cancer. Journal of Magnetic Resonance Imaging : Jmri. 38: 1501-9. PMID 23559453 DOI: 10.1002/Jmri.24119 |
0.246 |
|
| 2016 |
Skubitz KM, Geschwind K, Xu WW, Koopmeiners JS, Skubitz AP. Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors. Journal of Translational Medicine. 14: 51. PMID 26873324 DOI: 10.1186/S12967-016-0802-3 |
0.245 |
|
| 2014 |
Misemer BS, Skubitz AP, Carlos Manivel J, Schmechel SC, Cheng EY, Henriksen JC, Koopmeiners JS, Corless CL, Skubitz KM. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Medicine. 3: 81-90. PMID 24402778 DOI: 10.1002/Cam4.160 |
0.243 |
|
| 2007 |
Koopmeiners JS, Dowd BE, Carlin BP. Modeling and detecting potentially ruinous streaks in health expenditures. International Journal of Health Care Finance and Economics. 7: 23-42. PMID 17351750 DOI: 10.1007/S10754-007-9010-2 |
0.24 |
|
| 2017 |
Ito D, Childress M, Mason N, Winter A, O’Brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Rajwa B, Scott MC, Seelig D, Koopmeiners J, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma F1000research. 4: 42. DOI: 10.12688/F1000Research.6055.2 |
0.235 |
|
| 2012 |
Koopmeiners JS. A comparison of the autocorrelation and variance of NFL team strengths over time using a Bayesian state-space model Journal of Quantitative Analysis in Sports. 8. DOI: 10.1515/1559-0410.1422 |
0.229 |
|
| 2011 |
de Jong EP, van Riper SK, Koopmeiners JS, Carlis JV, Griffin TJ. Sample collection and handling considerations for peptidomic studies in whole saliva; implications for biomarker discovery. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 2284-8. PMID 21889499 DOI: 10.1016/J.Cca.2011.08.023 |
0.224 |
|
| 2014 |
Lee HY, Koopmeiners JS, Rhee TG, Raveis VH, Ahluwalia JS. Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention. Journal of Medical Internet Research. 16: e196. PMID 25164545 DOI: 10.1097/Ogx.0000000000000142 |
0.22 |
|
| 2017 |
Satori CP, Ramezani M, Koopmeiners JS, Meyer AF, Rodriguez-Navarro JA, Kuhns MM, Taylor TH, Haynes CL, Dalluge JJ, Arriaga EA. Checkpoints for Preliminary Identification of Small Molecules found Enriched in Autophagosomes and Activated Mast Cell Secretions Analyzed by Comparative UPLC/MS(e). Analytical Methods : Advancing Methods and Applications. 9: 46-54. PMID 28194233 DOI: 10.1039/C6Ay02500E |
0.219 |
|
| 2019 |
Boatman JA, Casty K, Vock DM, Murphy SE, Denlinger-Apte R, Smith TT, Hatsukami DK, Donny EC, Koopmeiners JS. Classification Accuracy of Biomarkers of Compliance Tobacco Regulatory Science. 5: 301-319. DOI: 10.18001/Trs.5.3.8 |
0.218 |
|
| 2017 |
Borgatti A, Winter AL, Stuebner K, Scott R, Ober CP, Anderson KL, Feeney DA, Vallera DA, Koopmeiners JS, Modiano JF, Froelich J. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study. Plos One. 12: e0172651. PMID 28222142 DOI: 10.1371/Journal.Pone.0172651 |
0.215 |
|
| 2021 |
Shi L, Hatsukami DK, Koopmeiners JS, Le CT, Benowitz NL, Donny EC, Luo X. A mixed effects model for analyzing area under the curve of longitudinally measured biomarkers with missing data. Pharmaceutical Statistics. PMID 34151513 DOI: 10.1002/pst.2146 |
0.211 |
|
| 2009 |
Jensen AR, Goldin AB, Koopmeiners JS, Stevens J, Waldhausen JH, Kim SS. The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis. Journal of Pediatric Surgery. 44: 183-9. PMID 19159741 DOI: 10.1016/J.Jpedsurg.2008.10.033 |
0.208 |
|
| 2009 |
Naito M, Shenoy A, Aoyama I, Koopmeiners JS, Komers R, Schnaper HW, Bomsztyk K. High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin. American Journal of Nephrology. 30: 99-111. PMID 19225232 DOI: 10.1159/000203619 |
0.207 |
|
| 2013 |
Kotandeniya D, Murphy D, Yan S, Park S, Seneviratne U, Koopmeiners JS, Pegg A, Kanugula S, Kassie F, Tretyakova N. Kinetics of O(6)-pyridyloxobutyl-2'-deoxyguanosine repair by human O(6)-alkylguanine DNA alkyltransferase. Biochemistry. 52: 4075-88. PMID 23683164 DOI: 10.1021/Bi4004952 |
0.206 |
|
| 2022 |
Guo J, Koopmeiners JS, Walmsley SJ, Villalta PW, Yao L, Murugan P, Tejpaul R, Weight CJ, Turesky RJ. The Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-]pyridine Hair Dosimeter, DNA Adductomics Discovery, and Associations with Prostate Cancer Pathology Biomarkers. Chemical Research in Toxicology. 35: 703-730. PMID 35446561 DOI: 10.1021/acs.chemrestox.2c00012 |
0.193 |
|
| 2016 |
Lee HY, Koopmeiners JS, McHugh J, Raveis VH, Ahluwalia JS. mHealth Pilot Study: Text Messaging Intervention to Promote HPV Vaccination. American Journal of Health Behavior. 40: 67-76. PMID 26685815 DOI: 10.5993/Ajhb.40.1.8 |
0.193 |
|
| 2017 |
Wolfson J, Koopmeiners JS, DiLernia A. Who’s good this year? Comparing the information content of games in the four major US sports Journal of Systems Architecture. 4: 153-163. DOI: 10.3233/Jsa-170199 |
0.191 |
|
| 2022 |
White CM, Tessier KM, Koopmeiners JS, Denlinger-Apte RL, Cobb CO, Lane T, Campos CL, Spangler JG, Hatsukami DK, Strasser AA, Donny EC. Preliminary evidence on cigarette nicotine reduction with concurrent access to an e-cigarette: Manipulating cigarette nicotine content, e-liquid nicotine content, and e-liquid flavor availability. Preventive Medicine. 107213. PMID 35995103 DOI: 10.1016/j.ypmed.2022.107213 |
0.184 |
|
| 2021 |
Jin J, Zhang L, Leng E, Metzger GJ, Koopmeiners JS. Multi-resolution super learner for voxel-wise classification of prostate cancer using multi-parametric MRI. Journal of Applied Statistics. 50: 805-826. PMID 36819087 DOI: 10.1080/02664763.2021.2017411 |
0.183 |
|
| 2020 |
Dermody SS, Tessier KM, Meier E, al'Absi M, Denlinger-Apte RL, Drobes DJ, Jensen J, Koopmeiners JS, Pacek LR, Tidey JW, Vandrey R, Donny E, Hatsukami D. An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33220047 DOI: 10.1093/ntr/ntaa236 |
0.182 |
|
| 2021 |
Jin J, Zhang L, Leng E, Metzger GJ, Koopmeiners JS. Bayesian spatial models for voxel-wise prostate cancer classification using multi-parametric magnetic resonance imaging data. Statistics in Medicine. PMID 34747059 DOI: 10.1002/sim.9245 |
0.181 |
|
| 2022 |
White CM, Watson C, Bravo Cardenas R, Ngac P, Valentin-Blasini L, Blount BC, Koopmeiners JS, Denlinger-Apte RL, Pacek LR, Benowitz NL, Hatsukami DK, Donny EC, Carpenter MJ, Smith TT. Early Changes in Puffing Intensity When Exclusively Using Open-Label Very Low Nicotine Content Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35524988 DOI: 10.1093/ntr/ntac118 |
0.179 |
|
| 2021 |
Carroll DM, Lindgren BR, Dermody SS, Denlinger-Apte R, Egbert A, Cassidy RN, Smith TT, Pacek LR, Allen AM, Tidey JW, Parks MJ, Koopmeiners JS, Donny EC, Hatsukami DK. Impact of nicotine reduction in cigarettes on smoking behavior and exposure: Are there differences by race/ethnicity, educational attainment, or gender? Drug and Alcohol Dependence. 225: 108756. PMID 34051544 DOI: 10.1016/j.drugalcdep.2021.108756 |
0.179 |
|
| 2020 |
Denlinger-Apte RL, Koopmeiners JS, Tidey JW, Luo X, Smith TT, Pacek LR, Joseph McClernon F, Jensen JA, Colby SM, Severson HH, Donny EC, Hatsukami DK. Support for a nicotine reduction policy among participants enrolled in a 20-week trial of very low nicotine content cigarettes. Addictive Behaviors. 106727. PMID 33261915 DOI: 10.1016/j.addbeh.2020.106727 |
0.173 |
|
| 2022 |
Kaizer AM, Koopmeiners JS, Kane MJ, Roychoudhury S, Hong DS, Hobbs BP. Basket Designs: Statistical Considerations for Oncology Trials. Jco Precision Oncology. 3: 1-9. PMID 35100726 DOI: 10.1200/po.19.00194 |
0.172 |
|
| 2021 |
Boatman JA, Vock DM, Koopmeiners JS. Borrowing from supplemental sources to estimate causal effects from a primary data source. Statistics in Medicine. PMID 34155662 DOI: 10.1002/sim.9114 |
0.169 |
|
| 2021 |
Kotalik A, Vock DM, Hobbs BP, Koopmeiners JS. A group-sequential randomized trial design utilizing supplemental trial data. Statistics in Medicine. 41: 698-718. PMID 34755388 DOI: 10.1002/sim.9249 |
0.169 |
|
| 2022 |
Ling SX, Hobbs BP, Kaizer AM, Koopmeiners JS. Calibrated dynamic borrowing using capping priors. Journal of Biopharmaceutical Statistics. 1-16. PMID 35129422 DOI: 10.1080/10543406.2021.1998100 |
0.167 |
|
| 2020 |
Kaizer AM, Koopmeiners JS, Chen N, Hobbs BP. Statistical design considerations for trials that study multiple indications. Statistical Methods in Medical Research. 962280220975187. PMID 33267746 DOI: 10.1177/0962280220975187 |
0.166 |
|
| 2023 |
Makielski KM, Sarver AL, Henson MS, Stuebner KM, Borgatti A, Suksanpaisan L, Preusser C, Tabaran AF, Cornax I, O'Sullivan MG, Chehadeh A, Groschen D, Bergsrud K, Pracht S, Winter A, ... ... Koopmeiners JS, et al. Oncolytic vesicular stomatitis virus is safe and provides a survival benefit for dogs with naturally occurring osteosarcoma. Biorxiv : the Preprint Server For Biology. PMID 37131624 DOI: 10.1101/2023.04.16.533664 |
0.163 |
|
| 2015 |
Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content Cancer Epidemiology Biomarkers and Prevention. 24: 472-476. DOI: 10.1158/1055-9965.EPI-14-0739 |
0.163 |
|
| 2021 |
Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Smith TT, Dermody S, Koopmeiners JS, Jensen JA, Strayer LG, Donny EC, Hatsukami D. Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young vs. Older Adult Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33754156 DOI: 10.1093/ntr/ntab049 |
0.159 |
|
| 2023 |
Deng C, Wolf JM, Vock DM, Carroll DM, Boatman JA, Hatsukami DK, Leng N, Koopmeiners JS. Practical guidance on modeling choices for the virtual twins method. Journal of Biopharmaceutical Statistics. 1-24. PMID 36876989 DOI: 10.1080/10543406.2023.2170404 |
0.159 |
|
| 2023 |
Haine LMF, Murry TA, Nahra R, Touloumi G, Fernández-Cruz E, Petoumenos K, Koopmeiners JS. Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials. Biostatistics (Oxford, England). PMID 37697901 DOI: 10.1093/biostatistics/kxad024 |
0.159 |
|
| 2022 |
Wolf JM, Koopmeiners JS, Vock DM. A permutation procedure to detect heterogeneous treatments effects in randomized clinical trials while controlling the type I error rate. Clinical Trials (London, England). 17407745221095855. PMID 35531765 DOI: 10.1177/17407745221095855 |
0.155 |
|
| 2024 |
Haine LMF, Murray TA, Koopmeiners JS. Optimal timing for an accelerated interim futility analysis incorporating real world data. Contemporary Clinical Trials. 107489. PMID 38461938 DOI: 10.1016/j.cct.2024.107489 |
0.144 |
|
| 2021 |
Masotti M, Zhang L, Leng E, Metzger GJ, Koopmeiners JS. A novel Bayesian functional spatial partitioning method with application to prostate cancer lesion detection using MRI. Biometrics. PMID 34806765 DOI: 10.1111/biom.13602 |
0.133 |
|
| 2024 |
Pestka DL, Boes S, Ramezani S, Peters M, Usher MG, Koopmeiners JS, Beebe TJ, Melton GB, Streib CD. Implementing Telestroke in the Inpatient Setting: Identifying Factors for Success. Stroke. PMID 38639090 DOI: 10.1161/STROKEAHA.123.046024 |
0.12 |
|
| 2023 |
Makielski KM, Sarver AL, Henson MS, Stuebner KM, Borgatti A, Suksanpaisan L, Preusser C, Tabaran AF, Cornax I, O'Sullivan MG, Chehadeh A, Groschen D, Bergsrud K, Pracht S, Winter A, ... ... Koopmeiners JS, et al. Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma. Molecular Therapy Oncolytics. 31: 100736. PMID 37965295 DOI: 10.1016/j.omto.2023.100736 |
0.115 |
|
| 2021 |
Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, ... ... Koopmeiners JS, et al. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. Eclinicalmedicine. 37: 100957. PMID 34195577 DOI: 10.1016/j.eclinm.2021.100957 |
0.095 |
|
| 2015 |
Ito D, Childress M, Mason N, Winter A, O'Brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Leary J, Seelig D, Koopmeiners J, Ruetz S, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 (+)/CD117 (+)/CD133 (+) lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000research. 4: 42. PMID 28357033 DOI: 10.12688/f1000research.6055.3 |
0.092 |
|
| 2012 |
Duffey B, Nguyen V, Lund E, Koopmeiners JS, Hulbert J, Anderson JK. Intermediate-term outcomes after renal cryoablation: results of a multi-institutional study. Journal of Endourology / Endourological Society. 26: 15-20. PMID 22050505 DOI: 10.1089/end.2011.0179 |
0.061 |
|
| 2022 |
Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, ... ... Koopmeiners JS, et al. Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial. Jama Network Open. 5: e222735. PMID 35294537 DOI: 10.1001/jamanetworkopen.2022.2735 |
0.06 |
|
| 2023 |
Lee HY, Xiong S, Sur A, Khang T, Vue B, Culhane-Pera KA, Pergament S, Torres MB, Koopmeiners JS, Desai J. Evaluating Human Papillomavirus eHealth in Hmong Adolescents to Promote Vaccinations: Pilot Feasibility Study. Jmir Formative Research. 7: e38388. PMID 37338961 DOI: 10.2196/38388 |
0.055 |
|
| 2024 |
Rizvi RF, Schoephoerster JA, Desphande SS, Usher M, Oien AE, Peters MM, Loth MS, Bahr MW, Ventz S, Koopmeiners JS, Melton GB. Decreasing Opioid Addiction and Diversion Using Behavioral Economics Applied Through a Digital Engagement Solution: Protocol for a Randomized Controlled Trial. Jmir Research Protocols. 13: e52882. PMID 38457203 DOI: 10.2196/52882 |
0.039 |
|
| 2013 |
Iroh Tam PY, Koopmeiners JS. Trends in pneumonia hospitalizations in Hennepin County, Minnesota, 1999-2010. Mayo Clinic Proceedings. 88: 1181-2. PMID 24079690 DOI: 10.1016/j.mayocp.2013.08.006 |
0.01 |
|
| Hide low-probability matches. |